Expression level of lipoprotein lipase in chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors

International Journal of Laboratory Hematology

Volumn 31, Issue 5, 2009, Pages 552-559

  Xu, W ^a   Li, J Y ^a   Shen, Q D ^a   Wu, Y J ^a   Yu, H ^a   Fan, L ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Chronic lymphocytic leukemia; IgVH mutational status; Lipoprotein lipase

Indexed keywords

CD19 ANTIGEN; CD20 ANTIBODY; CD38 ANTIGEN; CD5 ANTIGEN; GENOMIC DNA; IMMUNOGLOBULIN HEAVY CHAIN; LIPOPROTEIN LIPASE; MESSENGER RNA; PROTEIN KINASE ZAP 70;

ADULT; AGED; ARTICLE; CANCER STAGING; CHINESE; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN HEAVY CHAIN GENE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOMATIC HYPERMUTATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD38; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LIPOPROTEIN LIPASE; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROGNOSIS; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 70350230179     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2008.01078.x     Document Type: Article

References (25)

1. REFERENCES Bilban M., Heintel D., Scharl T., Woelfel T., Auer M.M., Porpaczy E., Kainz B., Krö ber A., Carey V.J., Shehata M.,Zielinski C., Pickl W., Stilgenbauer S., Gaiger A., Wagner O., Jäger U. & German CLL Study Group. (2006) Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression. Leukemia 20, 1080-1088.
2. Binet J.L., Auquier A., Dighiero G., Chastang C., Piguet H., Goasguen J., Vaugier G., Potron G., Colona P., Oberling F., Thomas M., Tchernia G., Jacquillat C., Boivin P., Lesty C., Duault M.T., Monconduit M., Belabbes S. & Gremy F. (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48, 198-206.
3. Bouley J., Deriano L., Delic J. & Merle- Beral H. (2006) New molecular markers in resistant B-CLL. Leukaemia & Lymphoma 47, 791-801.
4. Cheson B.D., Bennett J.M., Grever M., Kay N., Keating M.J., O'Brien S. & Rai K.R. (1996) National Cancer Institutesponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87, 4990-4997.
5. Damle R.N., Wasil T., Fais F., Ghiotto F., Valetto A., Allen S.L., Buchbinder A., Budman D., Dittmar K., Kolitz J., Lichtman S.M., Schulman P., Vinciguerra V.P., Rai K.R., Ferrarini M. & Chiorazzi N. (1999) IgV gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.\ ood 94, 1840-1847.
6. Dohner H., Stilgenbauer S., Benner A., eupolt E., Krober A., Bullinger L., ohner K., Bentz M. & Lichter P. 2000) Genomic aberrations and survival n chronic lymphocytic leukemia. ew England Journal of Medicine 343, 910-1916.
7. Hamblin T.J., Davis Z., Gardiner A., Oscier .G. & Stevenson F.K. (1999) Unmutated g V(H) genes are associated ith a more aggressive form of chronic ymphocytic leukemia. Blood 94, 1848-1854
8. Haslinger C., Schweifer N., Stilgenbauer ., Dö hner H., Lichter P., Kraut N., tratowa C. & Abseher R. (2004) Microarray ene expression profiling of B-cell hronic lymphocytic leukemia subgroups efined by genomic aberrations nd VH mutation status. Journal of linical Oncology 22, 3937-3949.
9. Heintel D., Kienle D., Shehata M., Krober ., Kroemer E., Schwarzinger I., Mitteregger ., Le T., Gleiss A., Mannhalter ., Chott A., Schwarzmeier J., Fonatsch ., Gaiger A., Dohner H., Stilgenbauer ., Jager U. & CLL Study Group. (2005) igh expression of lipoprotein lipase in oor risk B-cell chronic lymphocytic eukemia. Leukemia 19, 1216-1223.
10. Jelinek D.F., Tschumper R.C., Geyer S.M., one N.D., Dewald G.W., Hanson C.A., Stenson M.J., Witzig T.E., Tefferi A. & Kay N.E. (2001) Analysis of clonal Bcell D38 and immunoglobulin variable egion sequence status in relation to linical outcome for B-chronic lymphocytic leukaemia. British Journal of Haematology 115, 854-861.
11. Klein U., Tu Y., Stolovitzky G.A., Mattioli ., Cattoretti G., Husson H., Freedman ., Inghirami G., Cro L., Baldini L., Neri ., Califano A. & Dalla-Favera R. 001) Gene expression profiling of Bcell chronic lymphocytic leukemia eveals a homogeneous phenotype related o memory B cells. Journal ofExperimental Medicine 194, 1625-1638
12. Krober A., Seiler T., Benner A., Bullinger ., Bruckle E., Lichter P., Dohner H. & tilgenbauer S. (2002) V(H) mutation tus, CD38 expression level, genomicaberrations, and survival in chronic ymphocytic leukemia. Blood 100, 410-1416.
13. Mead J.R., Irvine S.A. & Ramji D.P. 2002) Lipoprotein lipase: structure, unction, regulation, and role in disease.Journal of Molecular Medicine 80, 753-769.
14. Montillo M., Hamblin T., Hallek M., ontserrat E. & Morra E. (2005) hronic lymphocytic leukemia: novel rognostic factors and their relevance or risk-adapted therapeutic strategies. Haematologica 90, 391-399.
15. Murthy V., Julien P. & Gagne C. (1996) Molecular pathobiology of the human lipoprotein lipase gene. Pharmacology and Therapeutics 70, 101-135.
16. Nuckel H., Huttmann A., Klein-Hitpass L., Schroers R., Fuhrer A., Sellmann L.,Duhrsen U. & Durig J. (2006) Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia. Leukaemia & Lymphoma 47, 1053-1061.
17. Oppezzo P., Vasconcelos Y., Settegrana C.,Jeannel D., Vuillier F., Legarff-Tavernier M., Kimura E.Y., Bechet S., Dumas G.,Brissard M., Merle-Bé ral H., Yamamoto M., Dighiero G., Davi F. & French Cooperative Group on CLL. (2005) The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia. Blood 106, 650-657.
18. Oscier D.G., Gardiner A.C., Mould S.J., Glide S., Davis Z.A., Ibbotson R.E., Corcoran M.M., Chapman R.M., Thomas P.W., Copplestone J.A., Orchard J.A. & Hamblin T.J. (2002) Multivariateanalysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 100, 1177-1184.
19. Preiss-Landl K., Zimmermann R., Hämmerle G. & Zechner R. (2002) Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism. Current Opinionin Lipidology 13, 471-481.
20. Rai K.R., Sawitsky A., Cronkite E.P., Chanana A.D., Levy R.N. & Pasternack B.S. (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46, 219-234.
21. Rosenwald A., Alizadeh A.A., Widhopf G., Simon R., Davis R.E., Yu X., Yang L., Pickeral O.K., Rassenti L.Z., Powell J., Botstein D., Byrd J.C., Grever M.R.,Cheson B.D., Chiorazzi N., Wilson W.H., Kipps T.J., Brown P.O. & Staudt L.M. (2001) Relation of gene expressionphenotype to immunoglobulin mutationgenotype in B cell chronic lymphocytic leukemia. Journal of Experimental Medicine 194, 1639-1647.
22. Stilgenbauer S., Bullinger L., Lichter P., Dohner H. & German CLL Study Group (GCLLSG). (2002) Chronic lymphocyticleukemia. Genetics of chronic lymphocytic leukemia: genomic aberrations andV(H) gene mutation status in pathogenesis and clinical course. Leukemia 16, 993-1007.
23. Vasconcelos Y., De Vos J., Vallat L., Rème T., Lalanne A.I., Wanherdrick K., Michel A., Nguyen-Khac F., Oppezzo P., Magnac C., Maloum K., Ajchenbaum- Cymbalista F., Troussard X., Leporrier M., Klein B., Dighiero G., Davi F. & French Cooperative Group on CLL. (2005) Gene expression profiling of chronic lymphocytic leukemia can discriminate cases with stable disease and mutated Ig genes from those with progressive disease and unmutated Ig genes. Leukemia 19, 2002-2005.
24. van't Veer M.B., Brooijmans A.M., Langerak A.W., Verhaaf B., Goudswaard C.S., Graveland W.J., van Lom K. & Valk P.J. (2006) The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia. Haematologica 91, 56-63.
25. Xu W., Li J.Y., Pan J.L., Qiu H.R., Shen Y.F., Li L., Wu Y.F. & Xue Y.Q. (2007) Interphase fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia. International Journal of Hematology 85, 430-436.